Results 231 to 240 of about 666,764 (304)

Should We Use Citizens' Assemblies to Make Health Policy?

open access: yesBioethics, EarlyView.
ABSTRACT This article assesses the normative case for using citizens' assemblies—small deliberative forums of randomly selected citizens—in health policymaking. Although they are increasingly popular, their normative justification remains underexplored. We reconstruct three possible rationales: Norman Daniels's ‘Accountability for Reasonableness’ (A4R)
Daniel Hutton Ferris, Johannes Kniess
wiley   +1 more source

“A Total Paradigm Shift”: Interviews With Australian Maternity Care Providers Who Practice Weight‐Inclusive Care

open access: yesBirth, EarlyView.
ABSTRACT Background Weight stigma is pervasive in maternity care, contributing to negative health outcomes and disengagement among larger‐bodied women. To reduce weight stigma and promote respectful, individualized care, a weight‐inclusive approach prioritizes overall well‐being rather than focusing on weight as a key health indicator.
Bec Jenkinson   +13 more
wiley   +1 more source

Off‐midline versus supraumbilical specimen extraction sites in robot‐assisted radical prostatectomy

open access: yesBJU International, EarlyView.
Objectives To compare two different specimen extraction sites (SES) (off‐midline [OM] vs. supraumbilical) for the incidence of incisional hernias (IHs) and to evaluate different risk factors for their occurrence after robot‐assisted radical prostatectomy.
Jonathan Vollemaere   +9 more
wiley   +1 more source

Visceral obesity augments prescription use: An analysis of the cross-sectional study of NHANES 2011-2018. [PDF]

open access: yesPLoS One
Acevedo-Fernández M   +6 more
europepmc   +1 more source

Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Incretin‐based therapies have gained momentum as a key strategy for reducing cardiovascular risk in individuals with obesity and/or type 2 diabetes (T2D). It remains unclear whether the cardiovascular benefits reflect a direct reduction in atherogenic lipoproteins—namely, low‐density lipoproteins (LDL), very low‐density lipoproteins (VLDL) and
Andrea Baragetti, Giuseppe Danilo Norata
wiley   +1 more source

Amylin analogues as a novel perspective in anti‐obesity therapy

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Public health systems face a major challenge because of the worldwide obesity epidemic. The number of obese individuals has increased dramatically and, even in Switzerland which may be considered a relatively “lean” country, the numbers are alarmingly high and have reached almost 50% of the adult population.
Thomas A. Lutz
wiley   +1 more source

Home - About - Disclaimer - Privacy